More funding is required to effectively fight the war against healthcare associated infections, and support is needed by the Centre for Healthcare Associated Infections (CHAI), whose research is taking that fight to the genetic level. This has been acknowledged by infection control specialists Tristel plc. Tristel, with its disinfection products, currently helps hospitals worldwide to fight HAIs on the front line. Tristel recently sponsored a fundraising gala dinner and charity auction for CHAI.
Tristel made a considerable donation towards the total funds raised of £26,500, helping to make the evening a great success. The event was organised by CHAI supporter Graziella Kontkowski, whose grandmother contracted C.diff and died after initially having been admitted to hospital for a urinary tract infection.
Further donations can be made to CHAI at www.hcai.nottingham.ac.uk.
Professor Richard James, director of CHAI, said: "The support of fundraising events such as this is vital in providing us with a cash lifeline to underpin research, at a time when the future of funding from central government is uncertain. Unlike other medical causes such as cancer, there is currently no national charity dedicated to raising money to fund research into these deadly bacteria."
The charity auctioneer for the night was ITN’s Alastair Stewart OBE who sold many of the exclusive lots to the Tristel team. These included a tour of the BBC and the chance to see the national TV news air live. In his speech, Alastair Stewart said: "This is an enemy that does not stand still and does not rest on its laurels, with a death toll of 37,000 in the last 10 years."
CHAI is aiming to raise £1.4 million to fund research into the clinical strains that cause serious infections such as MRSA, Clostridium difficile and Pseudomonas aeruginosa, a gram-negative bacterium which is particularly dangerous to those with weak immune systems, such as babies and young children.
Professor James continued: "This important research will examine the genetic differences between different strains of superbug, which will give us a greater insight into the mechanisms they use to multiply and attack the human body. It will be instrumental in helping us to develop rapid diagnostic tests for the detection of these evolving pathogens."